|
RPG Life Sciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
3795.70 Cr.
|
P/BV
|
6.59
|
Book Value (Rs.)
|
348.32
|
|
52 Week High/Low (Rs.)
|
2725/1733
|
FV/ML
|
8/1
|
P/E(X)
|
32.96
|
|
Bookclosure
|
27/06/2025
|
EPS (Rs.)
|
69.64
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 69.64 | 110.80 | 53.01 | 40.90 | 31.13 |
| Diluted EPS (Rs.) | 69.64 | 110.80 | 53.01 | 40.90 | 31.13 |
| Cash EPS (Rs.) | 82.63 | 123.76 | 63.33 | 50.27 | 40.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 366.06 | 320.80 | 226.67 | 186.00 | 154.66 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 366.06 | 320.80 | 226.67 | 186.00 | 154.66 |
| Dividend / Share (Rs.) | 0.00 | 24.00 | 16.00 | 12.00 | 9.60 |
| Revenue From Operations / Share (Rs.) | 427.83 | 395.12 | 351.96 | 310.09 | 266.16 |
| PBDIT / Share (Rs.) | 104.41 | 104.20 | 81.85 | 65.00 | 54.03 |
| PBIT / Share (Rs.) | 91.42 | 91.25 | 71.53 | 55.62 | 44.56 |
| PBT / Share (Rs.) | 93.24 | 140.82 | 71.26 | 55.44 | 44.24 |
| Net Profit / Share (Rs.) | 69.64 | 110.80 | 53.01 | 40.90 | 31.13 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 24.40 | 26.37 | 23.25 | 20.96 | 20.29 |
| PBIT Margin (%) | 21.36 | 23.09 | 20.32 | 17.93 | 16.74 |
| PBT Margin (%) | 21.79 | 35.63 | 20.24 | 17.87 | 16.62 |
| Net Profit Margin (%) | 16.27 | 28.04 | 15.06 | 13.19 | 11.69 |
| Return on Networth / Equity (%) | 19.02 | 34.53 | 23.38 | 21.98 | 20.12 |
| Return on Capital Employeed (%) | 23.89 | 28.04 | 30.97 | 29.05 | 27.86 |
| Return On Assets (%) | 14.52 | 27.85 | 17.09 | 16.12 | 14.93 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.97 | 1.12 | 1.25 | 1.34 | 1.36 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.30 | 3.88 | 2.28 | 2.57 | 2.58 |
| Quick Ratio (X) | 2.53 | 3.11 | 1.50 | 1.64 | 1.55 |
| Inventory Turnover Ratio (X) | 6.53 | 6.74 | 1.23 | 0.96 | 1.25 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 14.44 | 22.64 | 23.47 | 23.13 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 12.92 | 18.95 | 19.10 | 17.73 |
| Earning Retention Ratio (%) | 0.00 | 85.56 | 77.36 | 76.53 | 76.87 |
| Cash Earning Retention Ratio (%) | 0.00 | 87.08 | 81.05 | 80.90 | 82.27 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 194.01 | 277.95 | 300.80 | 346.74 | 171.83 |
| Interest Coverage Ratio (Post Tax) (%) | 126.02 | 163.32 | 195.80 | 219.19 | 100.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 2922.91 | 3626.89 | 2494.10 | 1093.81 | 855.55 |
| EV / Net Operating Revenue (X) | 4.13 | 5.55 | 4.29 | 2.13 | 1.94 |
| EV / EBITDA (X) | 16.93 | 21.05 | 18.43 | 10.18 | 9.58 |
| MarketCap / Net Operating Revenue (X) | 4.32 | 5.76 | 4.35 | 2.24 | 2.10 |
| Retention Ratios (%) | 0.00 | 85.55 | 77.35 | 76.52 | 76.86 |
| Price / BV (X) | 5.05 | 7.10 | 6.75 | 3.74 | 3.62 |
| Price / Net Operating Revenue (X) | 4.32 | 5.76 | 4.35 | 2.24 | 2.10 |
| EarningsYield | 0.03 | 0.04 | 0.03 | 0.05 | 0.05 |
